Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 20 family member A10, pseudogene (ANKRD20A10P) is a processed pseudogene in the human genome. Pseudogenes are genomic DNA sequences similar to normal genes but generally non-functional; they may lack the ability to encode a functional protein due to mutations or loss of regulatory elements. Some pseudogenes can affect gene regulation, for instance by acting as decoys for microRNAs or by producing noncoding RNAs, but there is no evidence that ANKRD20A10P has such a role. It is not associated with any known disease, nor is it a therapeutic or diagnostic target. ANKRD20A10P is not a receptor, enzyme, transporter, or other druggable protein. No direct biological, pathological, or pharmacological functions are currently established for this pseudogene. It is listed in genomic databases as a pseudogene with alternative names but no functional or clinical annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A10, pseudogene (ANKRD20A10P).